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The 5 ends of all picornaviral RNAs are linked covalently to
the genome-encoded peptide, VPg (or 3B). VPg linkage is
thought to occur in two steps. First, VPg serves as a primer for
production of diuridylylated VPg (VPg-pUpU) in a reaction cat-
alyzed by the viral polymerase that is templated by an RNA ele-
ment (oriI). It is currently thought that the viral 3AB protein is
the source of VPg in vivo. Second, VPg-pUpU is transferred to
the 3 end of plus- and/or minus-strand RNA and serves as
primer for production of full-length RNA. Nothing is known
about the mechanism of transfer. We present biochemical and
biological evidence refuting the use of 3AB as the donor for VPg
uridylylation. Our data are consistent with precursors 3BC
and/or 3BCDbeing employed for uridylylation. This conclusion
is supported by in vitro uridylylation of these proteins, the abil-
ity of a mutant replicon incapable of producing processed VPg
to replicate in HeLa cells and cell-free extracts and correspond-
ing precursor processing profiles, and the demonstration of
3BC-linked RNA in mutant replicon-transfected cells. These
data permit elaboration of our model for VPg uridylylation to
include the use of precursor proteins and invoke a possible
mechanism for location of the diuridylylated, VPg-containing
precursor at the 3 end of plus- or minus-strand RNA for pro-
duction of full-length RNA. Finally, determinants of VPg uridy-
lylation efficiency suggest formation and/or collapse or release
of the uridylylated product as the rate-limiting step in vitro
depending upon the VPg donor employed.
The picornavirus family of viruses causes a wide variety of
diseases in humans and animals (1). Poliovirus (PV),3 the caus-
ative agent of poliomyelitis, is the most extensively studied
member of this family and has proven to be a useful model
system for understanding picornavirus molecular biology,
including genome replication (1). PV is a nonenveloped virus
with a single-stranded RNA genome of positive polarity that is
7500 nt in length. As shown in Fig. 1A, the genome encodes a
single open reading frame flanked by 5- and 3-nontranslated
regions (NTRs). The genome contains a 22-amino acid peptide
(referred to as either VPg, 3B or primer for RNA synthesis)
covalently linked to its 5 end and is polyadenylated at its 3 end.
Translation of the genome is initiated from an internal ribo-
some entry site located in the 5-NTR, producing a 247-kDa
polyprotein that is co- andpost-translationally processed by the
virus-encoded 2A, 3C, and 3CD proteases (1). Although
polyprotein processing ultimately yields a set of processed end
products, processing intermediates will form during the course
of an infection, greatly increasing the functional proteome of
the virus. Processing intermediates located in the P2 (e.g. 2ABC,
2BC, etc.) and P3 regions of the polyprotein are likely important
for genome replication.
Our laboratory has been quite interested in defining the
molecular details of VPg attachment to the 5 end of picorna-
viral RNAs (2–5). This reaction is thought to occur in two inde-
pendent half-reactions catalyzed by the viral RNA-dependent
RNA polymerase, 3Dpol. First, VPg is uridylylated to produce
VPg-pUpU; second, VPg-pUpU serves as a primer for full-
length RNA synthesis (1). VPg uridylylation requires a tem-
plate. To date, two templates have been described. The first is
the poly(rA) tail at the 3 end of the genome (6). The second is
an RNA stem-loop structure found at different positions in the
genomes of different picornaviruses but most often occurring
in protein-coding sequence (7–11). We refer to this latter tem-
plate as oriI (origin of replication internal). PV oriI is located in
2C-coding sequence (Fig. 1A) (7).
Our current model for oriI-templated VPg uridylylation is
shown in Fig. 1B. This model is consistent withmuch of what is
known about this reaction (2–5, 7, 8, 11–19), but the details
have emerged from studies performed in vitro onminimal tem-
plates and minimal protein domains (2–5). Briefly, two mole-
cules of 3C(D) bind to oriI (step 1) (3). This complex isomerizes,
unwinding the stem and extending the loop (step 2) (3, 4).
3Dpol associates with the complex, directed and stabilized by
an interaction between the back of the “thumb” subdomain of
3Dpol and a convex surface formed by the top of both subunits
of the 3C dimer (step 3) (2–5). VPg joins the complex, perhaps
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by binding to the RNA-primer-binding site of 3Dpol in an
extended conformation (step 4) (19). In the presence of UTP,
Tyr-3 hydroxyl of VPg is used as a nucleophile to formVPg-pU,
the 3-OH of which, in turn, serves as the nucleophile to form
VPg-pUpU (step 5) (13). Both uridylate residues are templated
by a single adenylate residue in the oriI loop by using a slide-
back mechanism (13). VPg-pUpU must occur processively as
VPg-pU appears to be catalytically incompetent (20).
This model provides a clear mechanistic framework for the
study of oriI-templated VPg uridylylation in vitro. Importantly,
this model explains and predicts biological phenotypes (2, 4, 5,
20). However, VPg uridylylation occurs 10–50-fold slower in
vitro than necessary to support the rate constant (0.1/s) for
initiation calculated from biological data (see Ref. 21). In addi-
tion, this model assumes that the processed VPg peptide is the
primer employed in vivo, which may not be the case. Finally,
this model does not provide any hints of how a VPg-pUpU
molecule produced in themiddle of the genome could be trans-
ferred to the 3 end of plus- and/or minus-strand RNA for pro-
duction of the complementary RNA strand. Because the end
products of polyprotein processing may not be the forms of the
protein employed for assembly and/or function of the genome-
replication complexes in vivo, it is possible that the use of
polyprotein processing intermediates may be essential to reca-
pitulate VPg uridylylation in vitro that occurs on a biologically
relevant time scale, providing additional insight into the mech-
anism of this reaction that is absolutely essential for picornavi-
rus genome replication.
In this study, we show that P3 precursor proteins containing
VPg at the amino terminus (3BC and 3BCD) can be uridylylated
in vitro. 3BC-containing precursors bind to oriImore efficiently
than processed proteins and serve as VPg donors that can be
recruited to and/or retained in the uridylylation complex better
than processed VPg. We demonstrate an optimal affinity of
precursor binding to oriI for maximal accumulation of uridyly-
lated product in the steady state, suggesting formation and/or
collapse as a rate-limiting step for uridylylation in vitro. The use
of precursor proteins during replication in cells was queried by
preventing the production of processed VPg. Preventing VPg
formation in cells is not lethal and leads to production of 3BC-
linked RNA. Therefore, processed VPg is not essential for uri-
dylylation and/or full-length plus- and/or minus-strand RNA
synthesis in vivo. Analysis of the polyprotein processing profile
of the VPg-processing-defective mutant in cell-free extracts
uncovered two pathways of P3 precursor processing,major and
minor, and only themajor pathway was perturbed.We propose
that the minor pathway is responsible for production of pro-
teins (processing intermediates) required for uridylylation and
RNA synthesis. These studies provide new insight into the
mechanism of VPg uridylylation and suggest mechanisms for
transfer of the diuridylylated protein primer from themiddle of
the genome to the 3 end of plus- and/or minus-strand RNA.
EXPERIMENTAL PROCEDURES
Materials—Deep Vent DNA polymerase and restriction
enzymes were from New England Biolabs; shrimp alkaline
phosphatase was from U. S. Biochemical Corp.; T4 DNA ligase
was from Invitrogen; Difco-NZCYMwas from BD Biosciences;
QIAEX beads were from Qiagen; RNases A and T1 were from
Sigma; Ultrapure UTP solution was from GE Healthcare;
[-32P]UTP (6000 Ci/mmol) was from PerkinElmer Life Sci-
ences; synthetic VPg peptide was from Alpha Diagnostic Inter-
national (San Antonio, Texas); all other reagents and appara-
tuses were available through Fisher, VWR, or as indicated.
Construction of Expression Plasmids for 3BC, 3BCD, 3AB,
and 3Cpro—Standard PCR and cloning procedures were used
to generate expression plasmids for 3BC, 3BCD, 3AB, and
3Cpro. 3Cpro refers to 3C protein with an active protease. Oli-
gonucleotides used in PCRs for this study were purchased from
Invitrogen or IntegratedDNATechnologies, Inc; sequences are
provided in supplemental Table S1. Clones were verified by
sequencing at the Pennsylvania State Nucleic Acid Facility. A
detailed description of the cloning is provided in the supple-
mental material.
Bacterial Expression and Purification of 3BC, 3BC-Y3F,
3BCD, 3Cpro, 3AB, 3Dpol, and 3C—3Dpol and 3C were puri-
fied as described previously (2). Purification procedures for
wild-type 3BC, the 3BC Y3F mutant, 3BCD, 3Cpro, and 3AB
represented modifications of our published protocol. A
detailed description of the purification protocols is provided in
the supplemental material.
Transcription and Purification of 61-nt oriI—oriI for theVPg
uridylylation reactions and for the filter-binding assays was
transcribed from the pUC18–61-nt oriI plasmid (2) linearized
using the BstZ17I site. A complete protocol is provided in the
supplemental material.
FIGURE 1. Poliovirus genome organization and model for VPg uridylyla-
tion. A, schematic of the poliovirus genome. The 5 end of the genome is
covalently linked to a peptide (VPg) encoded by the 3B region of the genome.
The 3 end contains a poly(rA) tail. Three cis-acting replication elements are
known. oriL is located in 5-NTR. oriR is located in the 3-NTR. oriI is located in
2C-coding sequence for poliovirus; the position of this element is virus-de-
pendent. oriI is the template for VPg uridylylation. Translation initiation
employs an internal ribosome entry site (IRES). The single open reading frame
encodes a polyprotein. P1 encodes virion structural proteins as indicated. P2
encodes proteins thought to participate in virus-host interactions required
for genome replication. P3 encodes proteins thought to participate directly in
genome replication. Polyprotein processing is mediated by protease activity
residing in 2A, 3C, and/or 3CD proteins. B, model for VPg uridylylation. Step 1,
two 3C(D) molecules bind to oriI with the 3C domains contacting the upper
stem (solid lines) and the 3D domains contacting the lower stem (dashed
lines). Step 2, 3C dimer opens the RNA stem by forming a more stable interac-
tion with single strands forming the stem. Step 3, 3Dpol is recruited to and
retained in this complex by a physical interaction between the back of the
thumb sub-domain of 3Dpol and a surface formed by the 3C dimer. Step 4,
VPg is recruited to the complex. Step 5, two successive cycles of UMP incor-
poration yields VPg-pUpU by using a slide-back mechanism. Adapted from
Ref. 3.
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VPg Uridylylation Assays—Reactions were performed essen-
tially as described previously (2), with slight modifications.
Reaction mixtures contained 1 M 3Dpol, 1 M 61-nt oriI, in
reaction buffer (50 mM HEPES, pH 7.5, 10% glycerol, 5 mM
magnesium acetate, 10 mM -mercaptoethanol, 10 M UTP,
and 0.04 M [-32P]UTP (6000 Ci/mmol)). The concentrations
of 3BC, VPg, and 3Cwere 1Munless these were being titrated.
All reactions were adjusted to a final NaCl concentration of 20
mM. All components were diluted to working concentrations
immediately prior to use. Reactions were assembled on ice with
oriI, 3C, and VPg and/or 3BC, or 3BCD in reaction buffer. The
reactions were then transferred to 30 °C for 5 min and initiated
by addition of 3Dpol. Reactions were incubated at 30 °C for 20
min or the indicated amount of time during a time course and
quenched with an equal volume of 100mM EDTA in 75% form-
amide containing 0.05% bromphenol blue dye. Quenched reac-
tions were analyzed by using Tris-Tricine SDS-PAGE as
described previously (2).
3BC Cleavage by Using 3Cpro—Processing of 3BC by 3Cpro
was performed as follows. PV 3Cprowas freshly diluted to 6M
in dilution buffer (50 mM HEPES, pH 7.5, 10% glycerol, 5 mM
magnesium acetate, 10mM -mercaptoethanol). Following uri-
dylylation of 3BC for 20 min as described above, 3Cpro (60
pmol, 10 l of 6 M) was added to a 10-l aliquot of the uridy-
lylation reaction. This was then incubated at 30 °C for 60 min.
The reaction was quenched with an equal volume of quench
dye (100mM EDTA in 75% formamide containing 0.05% brom-
phenol blue), and the sample was analyzed by using Tris-
Tricine SDS-PAGE as described previously (2).
RNA Filter-binding Assays—Reaction mixtures (20 l) con-
tained 10 nM oriI and varying concentrations of 3BC, 3C, or 3C
andVPg in reaction buffer (50mMHEPES, pH7.5, 10% glycerol,
5 mMmagnesium acetate, 10 mM -mercaptoethanol). Binding
reactions were initiated by the addition of freshly diluted 3BC
(3C or 3C and VPg) to the RNA in reaction buffer. Reactions
were incubated at 30 °C for 15–20min.Membranes andWhat-
man 3MMpaperwere presoaked in equilibration buffer (50mM
HEPES, pH 7.5, and 5 mM magnesium acetate, and 10% glyc-
erol) for 2 min and assembled, in order from top to bottom,
nitrocellulose, nylon, andWhatman paper, in a slot blotter (GE
Healthcare). After assembly, the binding reactions (20 l) were
loaded into the slot blotter, and vacuumwas applied for 2min at
200mmHg.Membranes were air-dried and visualized by using
a Typhoon 8600 scanner in the storage phosphor mode and
quantified by using ImageQuant software.
Construction ofMutated Replicons—Standard PCR and clon-
ing procedures were used to generate poliovirus subgenomic
replicons containing the mutation of the Gln-Gly cleavage site
between 3B and 3C to Gly-Gly and for construction of the Y3F
mutant with a Gly-Gly mutation between 3B and 3C. A com-
plete description of the cloning is provided in the supplemental
material.
Transcription of Subgenomic Replicons and Luciferase
Assays—RNA transcripts for performing luciferase assayswere
generated from the pRLucRA plasmids after linearization with
ApaI. Luciferase assays were performed as described previously
(2) with slight modifications. A complete description of the
transcription reactions and the luciferase assays is provided in
the supplemental material.
Western Blot Analysis of Replicon Proteins—Cells were trans-
fected with replicon RNA and incubated at 34 °C for 20 h. Cells
were harvested and lysed, and Western blot analysis was per-
formed as described in the supplemental material.
Northern Blot Analysis—RNA isolation for Northern blot
analysis was performed as follows. HeLa cells (6  106) were
transfected by using electroporation as described abovewith 25
g of the indicated subgenomic RNAs (5 g/1.2  106 cells).
Cells were suspended in 30 ml of normal growth media and
incubated at 34 °C. Total RNA was then isolated from the cells
at the indicated times post-transfection using TRIzol reagent
(Invitrogen). Briefly, cells were pelleted by centrifugation at
1000  g for 4 min at 4 °C, washed with phosphate-buffered
saline (10 ml), and lysed in TRIzol reagent (1 ml). Lysed cells
were incubated at room temperature for 5min, and chloroform
(0.2ml)was added. The sampleswere vortexed vigorously (15 s)
and incubated at room temperature for 3 min. Samples were
centrifuged at 12,000  g for 15 min at 4 °C. Isopropyl alcohol
(0.5 ml) was added to the aqueous phase for each sample and
incubated at room temperature for 10 min. Following centrifu-
gation at 12,000  g for 10 min at 4 °C, the RNA pellet was
washed with 75% ethyl alcohol (1 ml) and then dissolved in
water (50 l). Concentration was determined bymeasuring the
absorbance at 260 nm. The quality of the RNA was assayed by
agarose gel electrophoresis, and the concentration of all of the
RNAs was normalized to the 18 S rRNA band by using the
Typhoon 8600 scanner in the fluorescence mode.
For Northern blot analysis, total RNA (5 g) was separated
on a 0.6% agarose gel containing 0.8 M formaldehyde. The gel
was thenwashed twice inwater for 30min each and then in 20
SSC (3 M sodium chloride, 0.3 M sodium citrate, pH 7.2) for 30
min. RNAwas transferred to nylonmembrane (HybondXL,GE
Healthcare) by using overnight capillary blotting using 10
SSC as the transfer buffer. RNA was cross-linked to the mem-
brane by using a Stratalinker 2400UVcross-linker (Stratagene).
Themembrane was dried and washed twice in wash buffer (1
SSC, 0.1% SDS) at 65 °C for 30 min each. Prehybridization was
performed inmodifiedChurch buffer (0.5 M sodiumphosphate,
pH 7.2, 7% SDS, 1 mM EDTA) for 4 h at 65 °C. Hybridization
probes were denatured at 95 °C for 5 min and chilled on ice for
1 min prior to addition to the membrane (1  107 cpm).
Hybridizationwas performed in themodifiedChurch buffer for
16 h at 65 °C. The membrane was washed twice in wash buffer
for 20 min at 65 °C and one time at room temperature. The
membranewas dried, wrapped in plastic wrap, and exposed to a
phosphor screen and scanned on a Typhoon 8600 scanner in
the storage phosphor mode and quantified by using Image-
Quant software.
Hybridization probes were made by PCR using oligonucleo-
tides 16 and 18 (supplemental Table S1) and pRLuc as template.
[-32P]dATP (1 mCi/ml and 3000 Ci/mmol; GE Healthcare)
was included in the PCR; the concentration of cold dNTPs was
3 mM for dCTP, dGTP, and dTTP and 500 M for dATP. The
quality of the PCR product was assayed by agarose gel electro-
phoresis. Scintillation counting was performed to determine
the counts/min for the probe.
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Immunoprecipitation of RNA—Total RNAwas prepared, and
concentration was measured as described above from HeLa
cells transfected with the wild-type, Gly-Gly mutant, or Y3F/
Gly-Gly mutant RNA. Total RNA was aliquoted equally into
three microcentrifuge tubes (30 g per aliquot), and IP buffer
(50mMTris, pH 7.4, 0.5 MNaCl, 1%Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS) was added to a final volume of 500 l.
Purified polyclonal anti-VPg, anti-3C, or anti-NS5A sera were
added to each tube. The mixtures were rotated at room tem-
perature for 45 min. Protein A magnetic beads (New England
Biolabs, 50 l) were conditioned by washing twice in IP buffer
and then suspended in IP buffer (50 l). These conditioned
beads were added to total RNA and anti-seramixture and incu-
bated for 1.5 h at room temperature. The beads were collected
by a magnetic stand (Dynal, Oslo, Norway) and washed four
times with IP buffer followed by two times with Tris buffer (50
mM Tris, pH 7.4, 150 mM NaCl). For Northern blotting, 5 l of
water and 15 l of formaldehyde loading dye (20 mM MOPS,
63.3% formamide, 23.3% formaldehyde, 5 mM sodium acetate,
4.3mMEDTA, 0.066% bromphenol blue, 0.066% xylene cyanol)
were added to the beads and incubated for 15min at 65 °C. The
beads were then pelleted and the entire volume loaded on a
denaturing gel for Northern blot analysis as described above.
Generation and Purification of Polyclonal PV VPg, PV 3C, PV
3D, and HCV NS5A Antisera—Polyclonal antibodies raised in
rabbits against viral proteins PV VPg, PV 3C-His, PV 3D, and
HCVNS5A-His were purified using ammonium sulfate precip-
itation and DEAE- Affi-Gel blue (Bio-Rad) column purification
as described in detail in the supplemental material.
HeLa/S10 Translation/Replication Reactions—Reactions
were performed as described previously (22) (method 3) with
the following modifications. Nuclease-treated rabbit reticulo-
cyte lysate (10% v/v) was used rather than initiation factors for
both the translation and replication reactions. [-32P]UTP
rather than [-32P]CTP was used for the replication reactions.
Radioimmunoprecipitations were performed as follows. A
100-l in vitro translation reaction set up in the presence of 1
mM guanidine HCl containing 50 Ci of [35S]methionine was
allowed to proceed at 30 °C for 3 h after which 8 l were
removed into 80 l of 1 SDS-PAGE sample buffer to serve as
the translation control. 1 ml of RIPA buffer (50 mM Tris, pH 8,
250 mM NaCl, 1% Triton X-100, 0.1% SDS) was then added to
the remainder of the reaction, and 100 l of a 50% slurry of
protein-G-agarose in RIPA buffer was added to preclear the
lysate. This was rotated at room temperature for 15–30 min.
The agarose was centrifuged at low speed (1000 rpm) for 1 min
and the supernatant removed into a fresh tube. An aliquot of
this pre-cleared lysate (150l) was then transferred into a fresh
tube containing 3l of rabbit specific antisera (3AB, 3B, 3C, 3D,
or preimmune antisera)4 and the samples incubated at room
temperature for 15 min. 70 l of a 50% slurry of protein G-aga-
rose was then added, and the tubes were rotated overnight at
4 °C. The agarose was pelleted by centrifugation at low speed
(1000 rpm) for 1 min, washed four times in RIPA buffer, and
suspended in 50 l of 1 SDS-PAGE sample buffer. The sam-
ples were heated to 80 °C and briefly spun prior to loading 15l
on a gel. The gels were fixed and then treated with amplify
solution before being exposed to autorad film.
RESULTS
Uridylylation of VPg Precursor Proteins—Two observations
in vitro point to the use of aVPg donor other than the processed
VPg peptide. First, the kinetics of VPg uridylylation are slow,
and the concentration of VPg required for maximal incorpora-
tion is high (2). It is generally believed that the 3AB precursor
protein serves as the donor for VPg in vivo given the high con-
centration of this protein in virus-infected cells (1, 23). How-
ever, other precursor proteins, for example 3BC and/or 3BCD,
are known to be present in picornavirus-infected cells (24).
Therefore, we expressed and purified poliovirus (PV) 3AB,
3BC, and 3BCD proteins (Fig. 2A) to determine whether or not
any of these proteins could serve as VPg donors in 3Dpol-cata-
lyzed, oriI-dependent uridylylation in vitro. 3AB did not display
any propensity to serve as a VPg donor (Fig. 2B, lane 3). 3C
protein has been shown to function as a stimulatory factor for
3Dpol in the VPg uridylylation reaction (2). Addition of 3C to
the 3AB uridylylation reaction did not alter the ability of 3AB to
serve as a VPg donor (Fig. 2B, lane 4). The 3BC protein, on the
other hand, was uridylylated efficiently by 3Dpol (Fig. 2B, lane
1). 3BC not only functioned as a VPg donor but also functioned
as the recruitment/retention factor for 3Dpol, as this reaction
did not require addition of 3C. Like 3BC, 3BCD was uridyly-
lated in the absence of 3C (Fig. 2B, lane 6).
To demonstrate that the 3BC(D) uridylylation product
occurred at the biologically relevant position, Tyr-3, we con-
structed, expressed, and purified a 3BC derivative in which
Tyr-3 was changed to Phe (3BC-Y3F). The 3BC-Y3F derivative
was not uridylylated by 3Dpol (Fig. 2B, lane 2).
Uridylylation of PV VPg occurs processively to form VPg-
pUpU (20). Processive uridylylation is likely essential as
VPg-pU does not chase into VPg-pUpU in vitro (20). In addi-
tion, a highly active 3Dpol derivative that produces muchmore4 I. G. Goodfellow, unpublished results.
FIGURE 2. 3BC and 3BCD are substrates for oriI-templated uridylylation in
vitro but 3AB is not. A, SDS-PAGE analysis of 2 g of each bacterially
expressed, purified protein employed in this study. 3AB, 3BC, 3BC-Y3F, and
3BCD are in lanes 1– 4, respectively. B, uridylylation of 3B-containing precur-
sors. oriI-templated uridylylation reactions were performed with VPg or the
indicated 3B-containing precursors (1 M). Reactions contained 61-nt oriI (1
M) and proceeded for 20 min. 3C (1 M) was present only when indicated
explicitly. The positions of uridylylated 3BCD, 3BC, and VPg are indicated.
C, proteolytic processing of uridylylated 3BC. Following the 20-min 3BC uri-
dylylation reaction, 3C protease was added for 1 h and resolved on a Tris-
Tricine gel to determine the extent of uridylylation (lane 2) relative to control
reactions performed with VPg peptide (lane 1).
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VPg-pU than VPg-pUpU under physiological conditions is
incapable of producing any RNA in cells (20). To determine the
stoichiometry of 3BC uridylylation, uridylylated 3BC was
cleaved in vitro by PV 3Cpro, and the uridylylated VPg product
was resolved by gel electrophoresis and compared with VPg-
pUpU produced in vitro fromVPg peptide (Fig. 2C). Only VPg-
pUpU was observed (compare lane 2 with lane 1 in Fig. 2C),
suggesting that 3BC uridylylation occurs processively.
3BC Is the Optimal VPg Donor in Vitro—To compare the
efficiency of 3BC(D) uridylylation to that of VPg, we evaluated
the kinetics of the reactions under conditions in which 3BC(D)
or VPg was present at a concentration of 1 M, stoichiometric
with 3Dpol and oriI (Fig. 3). These experiments showed that
3BC uridylylation was 10-fold faster than VPg uridylylation
(compare Fig. 3, A to B). At least 75% of the input 3BC was
uridylylated (Fig. 3A); only 25% of the VPg was uridylylated,
even after an incubation time of 20 min (Fig. 3B). In contrast,
the efficiency of 3BCD uridylylation was 10-fold lower than
VPg uridylylation (compare Fig. 3, C with B). The efficiency of
3BCD uridylylation could not be improved by increasing the
concentration of 3BCD employed (data not shown).
These data suggested that 3BC is the preferred VPg donor in
vitro. To probe the mechanistic basis for this observation, we
evaluated the 3BC concentration dependence of the rate of uri-
dylylation (Fig. 4A). This experiment revealed a cooperative
titration of 3BC under conditions in which oriI and 3Dpol were
present at a concentration of 1M. Therefore, theK0.5 value for
3BC must be less than 0.2 M.
Importantly, the rate of 3BC was
maximal at a stoichiometry of three
3BC molecules per oriI and 3Dpol.
These data are consistent with two
3BCmolecules binding to oriI coop-
eratively and with a higher affinity
than 3C (Fig. 4B). A third molecule
of 3BC then serves as the VPg
donor. Given a maximal rate of 3BC
uridylylation at a stoichiometry of
three or four, the K0.5 value of 3BC
for 3Dpol is likely lower than
observed for VPg (Fig. 4C). There-
fore, the efficiency (kcat/K0.5) of 3BC
uridylylation was at least 75-fold
higher than VPg uridylylation
because the (3BC)2-oriI complex
forms more efficiently, is more sta-
ble, and/or the VPg-donating 3BC
associates with this complex more
readily than VPg.
Formation and Collapse of (3C)2-
oriI-VPg Complex as Rate-limiting
Steps for Uridylylation—To follow
up on the observation that uridyly-
lation efficiency appeared to corre-
late with the stability of the 3C-con-
taining protein-oriI complex, we
used a filter-binding assay to meas-
ure the dissociation constants (Kd)
for the complexes of 3C, 3BC, or 3BCD with oriI (Fig. 5A).
Labeled oriI was incubated with increasing concentrations of
the indicated 3C-containing protein. The binding reactions
were given 15–20 min to reach equilibrium and then pulled
sequentially through nitrocellulose (binds protein-RNA com-
plex) and nylon (binds free RNA) membranes by attaching a
vacuum to a slot-blot apparatus (25). The filters were visualized
and quantified by using a PhosphorImager. Percentage of RNA
bound was plotted as a function of 3C-containing protein con-
centration and fit to the appropriate model as indicated in the
legend. In all cases, an end point of 80–90% was observed (Fig.
5A). The Kd values for 3C, 3BC, and 3BCD were as follows: 3 
0.1, 0.4  0.03, and 0.02  0.002 M, respectively.
Although previous studies demonstrated the ability of the 3D
domain to contribute to RNA binding by 3C (3), the ability for
the 3B domain to contribute to RNA binding by 3C is novel. An
optimalKd value exists for maximal uridylylation (Fig. 5B). The
actual uridylylation reaction is bracketed by two steps, each of
which can be extensively subdivided. The macro step prior to
uridylylation is formation of the uridylylation complex, which
includes association of the uridylylation substrate (VPg, 3BC, or
3BCD). The macro step after uridylylation is collapse of the
complex, which, at a minimum, requires release of the uridyly-
lated product. The observation of an optimal K0.5 value for
maximal uridylylation efficiency suggests that formation and
collapse of the 3C-containing protein-oriI complex can con-
tribute to the rate-limiting step for uridylylation in vitro. When
FIGURE 3. 3BC is the most efficient substrate for ori-templated uridylylation in vitro. Kinetics of 3BC (A),
VPg (B), and 3BCD (C) uridylylation were performed in reactions containing 1 M 3Dpol, 61-nt oriI template, and
either 1 M 3BC, VPg, or 3BCD. The VPg reaction contained 3C (1 M). Rates of uridylylation were obtained from
the linear portion of each curve. The rates were as follows: 0.54  0.02 M/min for 3BC (F), 0.062  0.002
M/min for VPg (f), and 0.007  0.002 M/min for 3BCD ().
FIGURE 4. 3BC enhances uridylylation complex assembly and serves as a better VPg donor. A, 3BC con-
centration dependence of the rate of 3BC uridylylation. The rate of 3BC uridylylation was determined from
reactions containing 1 M 3Dpol, 61-nt oriI template, and 3BC (0 –10 M) and then plotted as a function of 3BC
concentration. The K0.5 value for 3BC is estimated to be less than 0.2 M based on the stoichiometric binding
under the conditions employed (1 M oriI and 3Dpol). The dotted lines define the two phases of the titration as
determined by linear regression. The point of intersection was obtained algebraically. The intersection was
3.7  0.5 M. B, 3C concentration dependence of the rate of VPg uridylylation. The rate of VPg uridylylation was
determined from reactions containing 1 M 3Dpol, 61-nt oriI template, VPg, and 3C (0 –10 M). Rates were
plotted as a function of 3C concentration and fit to a hyperbola, yielding a K0.5 value of 1.1  0.04 M for 3C.
C, VPg concentration dependence of the rate of VPg uridylylation. The rate of VPg uridylylation was determined
from reactions containing 1 M 3Dpol, 61-nt oriI template, 3C, and VPg (0 –10 M). Rates were plotted as a
function of VPg concentration and fit to a hyperbola, yielding a K0.5 value of 1.3  0.04 M for VPg.
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complex dissociation is fast (e.g. (3C)2-oriI) or slow (e.g.
(3BCD)2-oriI) relative to uridylylation, then the observed
steady-state rate of uridylylation will be diminished. The exist-
ence ofmultiple steps other than uridylylation that can alter the
observed steady-state rate of uridylylation mandates caution
when comparing and contrasting uridylylation in vitro and
in vivo, when comparing and contrasting uridylylation in
different picornaviruses, and when interrogating the bio-
chemical mechanism by altering solution conditions and
reaction components.
Use of 3B-linkedPrecursors forGenomeReplication inVivo—As
alluded to above, the current models for picornavirus genome
replication indicate that 3AB is the donor for VPg and that
processed VPg is used in trans for production of VPg-pUpU,
which, in turn, is employed forminus- and/or plus-strand RNA
synthesis (15, 16, 26, 27). In contrast, our data are consistent
with a model in which 3BC(D) is employed as the VPg donor,
and formation of 3BC-pUpUwould be essential for turnover. If
processed VPg peptide must be produced and employed in
trans for genome replication, then a genome incapable of pro-
ducing VPg should be incapable of replication.
We mutated the cleavage site between 3B and 3C from Gln-
Gly to Gly-Gly to preclude formation of VPg (Fig. 6A). The
subgenomic replicon, pRLuc, was employed for this study as it
permits RNA synthesis to be monitored indirectly by monitor-
ing luciferase production (Fig. 6A). Here the mutated replicon
will be referred to as the Gly-Gly mutant. In addition, this Gly-
Glymutation was introduced into a replicon encoding a substi-
tution of the tyrosine nucleophile of VPg to phenylalanine to
ensure that any RNAproduced is initiated by using VPg instead
FIGURE 5. Maximal uridylylation requires an optimal affinity for oriI
implicating formation and/or collapse of the uridylylation complex as a
rate-limiting step for uridylylation in vitro. A, binding of 3C, 3BC, or 3BCD
to oriI. RNA binding was monitored by using a filter-binding assay. Radiola-
beled RNA (1 nM) was incubated with various concentrations of 3C, 3BC, or
3BCD for 15–20 min prior to separation of protein bound and free RNA on
nitrocellulose and nylon membranes, respectively, by using a slot-blot appa-
ratus. The percentage of RNA bound was plotted as a function of protein
concentration. The data for 3C (F) and 3BC (E) fit best to a Hill equation (B 
BmaxP
n/(Pn  K0.5
n), where B is total RNA bound; P is the concentration of
protein, and n is the Hill coefficient). The K0.5 values for 3C and 3BC were 3.2 
0.5 and 0.42  0.05 M, respectively, where n  2. The data for 3BCD (f) fit
best to a hyperbola yielding a K0.5 value of 0.016  0.002 M. B, changes in
uridylylation efficiency as a function of oriI-binding affinity. The rate of
VPg/3C (F), 3BC (E), and 3BCD (f) uridylylation plotted as a function of the
K0.5 values for the interaction with oriI as determined in A for 3C, 3BC, and
3BCD.
FIGURE 6. Release of 3B(VPg) from the polyprotein is not essential for
genome replication in HeLa cells or cell-free extracts, providing evi-
dence for the use of precursor forms of 3B in vivo. A, schematic of PV
subgenomic replicon. The Gln-Gly (or QG) processing site between 3B and 3C
in wild-type (WT) was changed to Gly-Gly (or GG) to prevent release of 3B
peptide. The Gly-Gly junction was also introduced into a replicon encoding a
3B with a substitution of Tyr-3 to Phe. Tyr-3 is the nucleophile employed to
form VPg-pU. B, replication of in vitro transcribed replicon RNA in HeLa cells:
wild type (F), Gly-Gly mutant (f), and Y3F/Gly-Gly mutant (). As a control,
wild-type replicon RNA was evaluated in the presence of guanidine hydro-
chloride, an inhibitor of replication (E). HeLa cells were transfected with in
vitro transcribed replicon RNA, placed at 34 °C, and luciferase activity was
monitored for 20 h post-transfection. C, replication of in vitro transcribed rep-
licon RNA in HeLa cell-free extracts. HeLa S10 extracts containing [-32P]UTP
were primed with wild-type, Gly-Gly, or Y3F/Gly-Gly subgenomic replicon
RNA and then analyzed by 1% native agarose gel electrophoresis. Shown is a
phosphorimage after a 2-day exposure for wild-type (lane 1) and after a 3-day
exposure for Gly-Gly mutant (lane 2) and Y3F/Gly-Gly mutant (lanes 3). The
three forms of newly synthesized RNA products (replicative form (RF), repli-
cative intermediate (RI), and single-stranded, genomic RNA (ss)) are indicated.
Ribosomal RNA (rRNA) was used as a loading control. RLU, relative light units.
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of some alternative, irrelevant mechanism (Fig. 6A). This repli-
con will be referred to as the Y3F/Gly-Gly mutant. These rep-
liconswere electroporated intoHeLa cells andmaintained at 37
or 34 °C; luciferase activity was monitored for 20 h post-trans-
fection (Fig. 6B). At both temperatures, the Gly-Gly replicon
was capable of replication (Fig. 6B and data not shown). At
37 °C, the Gly-Gly mutant replicated to within 15-fold of wild-
type replicon (data not shown); at 34 °C, the Gly-Gly mutant
replicated to within 5-fold of wild-type replicon (Fig. 6B). In all
cases, Gly-Glymutant replication employedVPg priming as the
Y3F/Gly-Gly mutant did not display any significant increase in
luciferase activity over that attributable to translation of the
input RNA. The kinetics of luciferase production for this
mutant was on par with that observed for wild-type replicon in
the presence of 3 mM guanidine hydrochloride, a replication
inhibitor for poliovirus (Fig. 6B). These data suggest that pro-
cessed VPg is not essential for genome replication.
Given the reduced kinetics and temperature sensitivity of
Gly-Gly mutant replication, it was possible that a revertant was
selectively amplified in the cell-based experiments. It is impor-
tant to note that this possibility has never been documented.
Nevertheless, we evaluated RNA synthesis of mutant replicons
by using a cell-free system (22) that would preclude this possi-
bility. Briefly, HeLa S10 extracts containing [-32P]UTP were
programmed with the mutated replicon RNAs; reaction prod-
ucts were resolved by agarose gel electrophoresis and visualized
by autoradiography. Reaction products include the following:
single-stranded, genomic RNA (ssRNA in Fig. 6C); minus-
strand RNA product hybridized to plus-strand template,
the so-called replicative form RNA (RF RNA in Fig. 6C); and
minus-strand RNA template harboring multiple copies of nas-
cent plus-strand RNA of various lengths, the so-called replica-
tive intermediate (RI RNA in Fig. 6C). The Gly-Gly mutant was
capable of replicating as all expected reaction products were
observed (lane 2 of Fig. 6C). The level of Gly-Gly mutant repli-
cationwas reduced relative towild-type replicon (compare lane
2 to lane 1 in Fig. 6C). Notably, wild-type RNA could be
observed after a 2-day exposure; however, detection of mutant
RNA required a 3-day exposure. Therefore, theGly-Glymutant
may be more debilitated in RNA synthesis than evident from
monitoring luciferase activity. Interestingly, the ratio of plus-
strand RNA:minus-strand RNA (ssRNA:RF RNA) was reduced
2-fold. The significance of this observation is unclear. RNA
synthesis by the Gly-Gly mutant required VPg priming as the
Y3F/Gly-Gly mutant failed to produce any RNA (lane 3 of Fig.
6C). These data provide further support for the notion that
processed VPg is not essential for genome replication.
To evaluate processing of 3B-containing precursors directly,
cells were transfected with wild-type or Gly-Gly mutant repli-
cons and harvested at 20 h post-transfection. Lysates were ana-
lyzed by Western blotting using polyclonal antibodies raised
against poliovirus 3D, 3C, and 3AB proteins (Fig. 7A). Wild-
type replicon produced 3CD and 3D; however, the Gly-Gly
mutant replicon failed to produce 3CD (anti-3D in Fig. 7A).
Wild-type replicon produced 3C; however, the Gly-Glymutant
replicon failed to produce 3C but accumulated 3ABC and 3BC
(anti-3C in Fig. 7A). Finally, wild-type replicon produced 3AB,
but the Gly-Gly mutant replicon failed to produce 3AB but
produced 3ABC and 3BC instead (anti-3AB in Fig. 7A). We
conclude that cryptic processing events leading to production
of processed VPg that could account for RNA synthesis are
unlikely.
The observation that the Gly-Gly mutant replicon failed to
produce 3C and 3CD was expected (Fig. 7A). However, this
FIGURE 7. Analysis of polyprotein processing by the Gly-Gly mutant
reveals the existence of two independent pathways for P3 precursor
processing. A, processing evaluated by Western blotting. HeLa cells were
transfected with wild-type or Gly-Gly mutant RNA, placed at 34 °C, harvested
20 h post-transfection, and extracts prepared and processed for Western blot-
ting as described under “Experimental Procedures.” Antisera against 3Dpol,
3C, and 3AB were employed. The bands corresponding to the different pre-
cursor and processed proteins are indicated. B, processing evaluated by cell-
free translation. HeLa cell-free translation extracts containing [35S]methi-
onine and [35S]cysteine were programmed with wild-type, Gly-Gly mutant, or
Y3F/Gly-Gly mutant RNA. Radiolabeled proteins were separated by 15% SDS-
PAGE and detected by phosphorimaging. The bands corresponding to the
different precursor and processed proteins expected for wild-type replicon
are indicated on the left. Luc denotes the luciferase reporter. The identity of
bands unique to the mutant are indicated on the right. C, assignment of
bands unique to the Gly-Gly mutants by immunoprecipitation. Products from
cell-free translation reactions of wild-type and Gly-Gly mutant replicon RNAs
were immunoprecipitated using antiserum raised against 3AB, VPg, 3C, or 3D
protein; preimmune serum was employed as a negative control. The precip-
itated proteins were separated by 15% SDS-PAGE and detected by phospho-
rimaging. The location of the various precursor and processed proteins are
indicated on the left. D, processing of the P3 precursor occurs by two inde-
pendent pathways. There are major (I) and minor (II) pathways. In pathway I,
processing between 3B and 3C yields 3AB and 3CD. In pathway II, processing
between 3A and 3B yields 3A and 3BCD. 3BCD processing yields 3BC and 3D;
3BC processing yields 3B and 3C. Pathway II is proposed to function in
genome replication and is not perturbed in the Gly-Gly mutant.
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observationhighlighted the possibility that the reduced kinetics
and temperature sensitivity of Gly-Gly mutant replication
could be attributable to incomplete polyprotein processing as
dogma states that 3C and 3CDare the proteases that function in
the infected cell (1, 23). To address this issue, it was important
to use an approach that would be as unbiased as possible.
Therefore, we again turned to the cell-free system. HeLa S10
extracts containing 35S-Met and 35S-Cys were programmed
with wild-type or mutant replicon RNA. Translated products
were resolved by denaturing PAGE and visualized by autora-
diography. Surprisingly, the processing profile of the mutant
polyproteins (lanes 2 and 3 of Fig. 7B) was very similar to the
wild-type polyprotein (lane 1 of Fig. 7B). The key differencewas
that two new products appeared that were consistent with pro-
cessed 3D and the 3ABC precursor (lanes 2 and 3 of Fig. 7B).
We conclude that precursor forms of 3C other than 3CD are
capable of processing the P2-P3 polyprotein.
To identify the bands thatwere unique to theGly-Glymutant
polyprotein, products present in translation reactions were
immunoprecipitated with antiserum raised against 3AB, VPg,
3C, or 3D; preimmune serum was employed as a negative con-
trol (Fig. 7C). The pulldown experiments were consistent with
the unique bands being 3D (precipitated only by anti-3D
serum) and 3ABC (precipitated by all sera except the anti-3D
serum) (Fig. 7C).
Unexpectedly, this experiment revealed the existence of two
independent processing pathways for the P3 (3ABCD) precur-
sor, and only one of these was altered by impairing cleavage at
the 3B-3C junction. Processing of P3 via pathway I was the
major pathway and produces 3AB and 3CD (Fig. 7D). 3AB and
3CD were the primary products of P3 cleavage observed for
wild-type replicon (Fig. 7, B and C). Pathway II is the minor
pathway and produces 3A and 3BCD (Fig. 7D). 3A and 3BCD
are the second-most abundant products of P3 cleavage
observed for wild-type replicon (Fig. 7, B and C). This minor
pathway may also give rise to 3C and 3D (the active form of the
polymerase) (Fig. 7D) as high levels of these proteins could not
be detected for wild-type replicon by using metabolic labeling
or immunoprecipitation (Fig. 7, B and C). The observation that
PVmultiplication becomes resistant to cycloheximide 3 h post-
infection suggests that very little 3Dpol is required for replica-
tion (28).
In this model, pathway II would yield VPg, originating from
3BC rather than 3AB (Fig. 7D). Pathway II was unchanged for
the Gly-Gly mutant replicon as the levels of 3A and 3BCDwere
unchanged relative to wild-type replicon (Fig. 7C). In contrast,
inactivation of the 3B-3C cleavage site led to activation of the
3C-3D cleavage site, yielding 3ABC and 3D (Fig. 7, B and C).
Although it is possible that 3ABCperforms all of the function of
3AB, the literature would suggest 3D and 3CD have distinct,
nonoverlapping functions. The reduced kinetics and tempera-
ture sensitivity of genome replication may be caused by the
absence of 3CD functions.
Gly-Gly Mutant Produces Full-length, 3BC-linked RNA—The
use of luciferase activity as a measure of RNA synthesis by a
mutant replicon does not establish unambiguously that the
RNAproduced is full length or that the kinetics of RNA synthe-
sis are truly equivalent to wild-type replicon. Therefore, we iso-
lated total RNA from cells transfected with wild-type, Gly-Gly
mutant, or Y3F/Gly-Gly mutant replicon as a function of time
post-transfection. RNA was run on a denaturing agarose gel,
transferred to a nylon membrane, and probed with a 32P-la-
beled PCR product representing a portion of the 3D gene.
Hybridized probe was visualized and quantified by phospho-
rimaging. The Gly-Gly mutant produced full-length RNA that
was dependent on VPg priming (compare 3B-3C-Gly-Gly with
3BC-Gly-Gly-Y3F in Fig. 8A). Surprisingly, the kinetics of RNA
synthesis appeared slower, and the final yield of RNA appeared
FIGURE 8. RNA produced by the Gly-Gly mutant is full length and
covalently linked to 3BC. A, kinetics of RNA synthesis by wild-type, Gly-Gly
mutant, and Y3F/Gly-Gly mutant monitored by Northern blotting. HeLa cells
were transfected with in vitro transcribed replicon RNA and placed at 34 °C. At
the indicated times, total RNA was isolated from transfected HeLa cells, sep-
arated on a 0.6% agarose gel containing 0.8 M formaldehyde, transferred to
nylon membrane, and hybridized with a 32P-labeled DNA probe. The hybrid-
ized DNA probe was visualized by phosphorimaging. Shown is a phospho-
rimage after a 6-h exposure for wild-type and after a 24-h exposure for Gly-Gly
and Y3F/Gly-Gly mutants. In vitro transcribed RNA is shown as a reference.
B, quantification of data shown in A: wild-type (F), Gly-Gly mutant (GG) (f), and
Y3F/Gly-Gly mutant (Y3F/GG) (). C, interrogation of protein linkage to wild-
type and Gly-Gly mutant RNA by RNA immunoprecipitation and Northern
blotting. HeLa cells were transfected with wild-type, Gly-Gly mutant, or Y3F/
Gly-Gly mutant RNA and placed at 34 °C. Total RNA was isolated from trans-
fected HeLa cells and immunoprecipitated using antibodies against VPg, 3C,
or HCV NS5A (as a negative control). The immunoprecipitated RNA was
detected by Northern blotting as described above. Shown is a phosphorim-
age after a 1-day exposure for wild-type and after a 5-day exposure for Gly-Gly
mutant and Y3F/Gly-Gly mutant.
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lower than anticipated based on the luciferase activity for the
Gly-Gly mutant relative to wild type. Quantitation of the
Northern blot showed that the Gly-Glymutant exhibited a lon-
ger lag phase than observed by monitoring luciferase activity
(compare Fig. 8B to Fig. 6B). In addition, the final yield of Gly-
Glymutant RNAwas 30-fold lower than observed for wild-type
RNA (Fig. 8B). This value is 6-fold lower than observed bymon-
itoring luciferase activity (compare Fig. 8B to Fig. 6B). These
data suggest that each plus-strand, Gly-Gly-mutant RNA mol-
ecule synthesized is translated for a longer time than each wild-
type RNA molecule. We conclude that the Gly-Gly mutant
exhibits a defect in the switch from translation to replication.
All of the data accumulated to this pointwere consistentwith
a 3B(VPg)-containing precursor being employed for Gly-Gly
mutant RNA synthesis. To identify the precursors associated
withGly-Glymutant RNA, total RNAwas immunoprecipitated
by using antisera raised against PVVPg(3B), 3C, 3Dpol, or hep-
atitis C virus NS5A (as a negative control). RNA was processed
for Northern blotting as described above. The Gly-Gly mutant
RNA was immunoprecipitated by anti-VPg and anti-3C sera
(Fig. 8C) but not by anti-3D (data not shown) or anti-NS5A
serum (Fig. 8C). Importantly, only anti-VPg serumwas capable
of immunoprecipitating wild-type RNA (Fig. 8C). A signal
could not be detected with any antiserum when Y3F/Gly-Gly
mutant-transfected cells were the source of the total RNA
employed for the experiment. Therefore, this experiment is
detecting replicated RNA not transfected RNA. We conclude
that Gly-Gly mutant RNA is covalently linked to the 3BC pre-
cursor protein.
DISCUSSION
The 5 ends of picornaviral plus- andminus-strandRNAs are
linked covalently to a short peptide termed VPg (virion protein
genome-linked) encoded by the 3B region of the genome. It has
been thought for a long time that VPg-RNA is produced in two
steps as follows: 1) production of VPg-pUpU from VPg; and 2)
production of VPg-RNA from VPg-pUpU (1, 23). The discov-
ery that VPg uridylylation is templated by a cis-acting replica-
tion element (CRE) located at an internal position (oriI) rather
than the 3-poly(rA) tail further
complicated the mechanism of
VPg-RNA synthesis as VPg-pUpU
needed to be transferred from the
internal site of uridylylation to the
3-terminal site for elongation (7).
Whether VPg or some precursor
thereof is uridylylated is not clear.
Most models suggest that the viral
3AB protein is either uridylylated or
the source of VPg that goes on to be
uridylylated (Fig. 9) (15, 16, 26, 27).
However, it is possible that precur-
sors other than 3AB serve as sub-
strates for uridylylation, for exam-
ple 3BC or 3BCD (Fig. 9). The use of
larger precursors like 3BCD pro-
vides a mechanism for transfer. For
example, 3BCDbound to theCRE at
the 3 end of the genome (oriR) could be used for uridylylation
at oriI, and release from the uridylylation complexwould return
uridylylated 3BCD to the 3 end for extension and production
of full-lengthRNA (Fig. 9). oriR has been shown to influence the
start site for minus-strand synthesis in Coxsackievirus B3 (29).
The proposed organization of the uridylylation complex pre-
dicts that use of this complex will always be in trans (Fig. 9) (5).
However, the origin of 3BCD-CRE employed for uridylylation
could be intra- (Fig. 9) or intermolecular. An intermolecular
origin would permit 3BCD bound to a CRE located in the
minus-strand to use this complex for plus-strand synthesis,
consistent with the known requirement of oriI for plus-strand
synthesis (11, 15, 16). Therefore, knowledge of the precursor
employed for uridylylation has significant implications for
mechanism(s) employed for production of picornaviral VPg-
linked RNA.
As indicated above, most models for picornavirus genome
replication show 3AB as the VPg-containing precursor pro-
tein contributing to uridylylation (1, 15, 16, 23, 26, 27). This
conclusion appears to be based solely on the abundance of
this protein in virus-infected cells. Although 3AB uridylyla-
tion has been shown to occur in the presence of Mn2 (30),
we were unable to observe 3AB uridylylation in the presence
of Mg2 (lanes 3 and 4 of Fig. 2B), a condition supporting
robust VPg uridylylation (lane 5 of Fig. 2B). Mn2 is seldom
the preferred divalent cation employed by polymerases in
vivo and is known to substantially relax substrate specificity
of PV 3Dpol (31, 32). In contrast to 3AB, both 3BC and 3BCD
were uridylylated in the presence of Mg2 (lanes 1 and 6 of
Fig. 2B). These observations are consistent with a recent
structure for the 3Dpol-VPg complex from foot-and-mouth
disease virus that located the VPg amino terminus in the
polymerase active site (33). 3AB would not be able to locate
its VPg domain in the 3Dpol active site without reorganizing
the active site in a manner that would be predicted to sub-
stantially reduce nucleotidyl transfer activity. Worth noting,
foot-and-mouth disease virus 3BC is also uridylylated (34).
These data are consistent with 3BC(D) being employed for
uridylylation instead of VPg.
FIGURE 9. Hypothetical model for use of precursors bound to 3 end of plus- or minus-strand RNA for
uridylylation and production of full-length RNA. Assembly and organization of the uridylylation complex
are essentially as indicated in Fig. 1B. This study demonstrates that 3CD can be replaced by 3BCD in vitro and in
vivo, forming a more stable interaction with oriI. Two 3BCD molecules bind to oriI to form the (3BCD)2-oriI
complex (step 1) that isomerizes (step 2) to form the complex competent for recruitment of and utilization by
3Dpol (step 3). The VPg donor associates with the complex. Three possible VPg donors have been shown in this
study as follows: VPg, 3BC, and 3BCD. Use of 3BCD is the preferred hypothesis because this protein can bind to
the 3 end of plus- and minus-strand RNA and join the uridylylation complex via an intra- or intermolecular
interaction (step 4; data not shown). 3BCD uridylylation would occur (step 5; data not shown) and the uridyly-
lated 3BCD would be released and returned to the 3 end for extension (step 6). The mechanism for elongation,
timing of 3BCD proteolysis relative to RNA elongation, etc. remain unexplored.
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Inhibiting processing between picornaviral 3A and 3B pro-
teins is lethal for genome replication (26); however, inhibiting
processing between 3B and 3C is not (Gly-Gly mutant, Fig. 6)
(35). The kinetics of Gly-Gly mutant RNA synthesis was tem-
perature-sensitive and slow relative to wild type (Fig. 6 and Fig.
8, A and B). Importantly, 3BC-linked RNA was clearly made
(Fig. 8C). 3BCD-linked RNA was not observed (data not
shown). Together, these data support a model in which 3A-3B
processing occurs to form 3BCD, which is subsequently uridy-
lylated. Extension of 3BC(D)-pUpU leads to 3BC-RNA, which
in turn leads to VPg-RNA. Therefore, proteolytic processing of
the P3 precursor may represent an important mechanism for
regulating the transition from initiation to elongation during
RNA synthesis and the transition from genome replication to
genome encapsidation. Infectious virus particles were not
observed for the Gly-Gly mutant (data not shown). These data
strongly support the ability of P3 precursors containing 3B at
the amino terminus to be uridylylated in vivo and rule out the
requirement for processed VPg.
We observed that the uridylylation efficiency of 3BC was
10-fold greater than VPg and that the uridylylation efficiency
of VPg was 10-fold greater than 3BCD (Fig. 3). 3BC was a
better oriI-binding protein than 3C (Fig. 5) as well as a better
VPg donor than the VPg peptide (Fig. 4). These data suggest
that 3B contributes to the RNA-binding affinity of 3C. It has
been shown that 3AB is an RNA-binding protein and the RNA-
binding determinant maps to 3B as 3A lacks demonstrable
RNA binding activity (36, 37). The carboxyl-terminal two-
thirds of picornaviral 3B proteins contain several basic amino
acid residues (38). Therefore, 3B may interact with the phos-
phodiester backbone of oriI in or around the loop. 3B also con-
fers increased binding affinity to 3CD as the Kd value for 3BCD
binding to oriI is 10-fold lower than that reported by us previ-
ously for 3CD (Fig. 5) (3). The ability for 3C to contribute to the
affinity of VPg binding to the uridylylation complex could be
facilitated by 3BC-3C and/or 3BC-3D interaction. In this case,
the 3B domain would direct binding to 3Dpol, and the 3C
domainwould increase retention time of 3B in the uridylylation
complex by interacting with 3C and/or 3D domains of 3CD.
The structure of PV 3CD identified numerous possibilities for
3C-3D interaction surfaces that are independent of those that
contribute to formation of the (3C)2-3Dpol core of the uridyly-
lation complex (39). Retention of 3BCD in the uridylylation
complex may be enhanced over that observed for 3BC by using
its 3D domain for additional interactions with components of
the uridylylation complex.
Studies of oriI-templated VPg uridylylation in vitro are gen-
erally performed under steady-state conditions, i.e. the concen-
tration of VPg is much greater than the other components of
the reaction; multiple turnovers occur (2–5, 7–9, 11, 12, 14, 34,
38, 40, 41). The rate of VPg uridylylation under standard con-
ditions is too slow to support the rate of replication observed in
vivo (3, 21). Unfortunately, the rate-limiting step(s) for VPg
uridylylation is not known, thus precluding an explanation for
the “inefficiency” of the reaction. The existence of an optimal
equilibrium dissociation constant of the 3C-containing pro-
tein-oriI complex (Fig. 5B) for themaximal rate of uridylylation
suggests that both formation and collapse of the uridylylation
complex contribute to the rate-limiting step. The observation
of an inverse correlation between uridylylation efficiency and
theK0.5 value for the VPg donor (Fig. 4) suggests that the kinet-
ics of release of the VPg donor and/or its uridylylated products
contribute to the rate-limiting step. We propose that the
reduced affinity of 3C for oriI relative to 3C-containing precur-
sors would cause formation and/or collapse of the (3C)2-oriI
complex to both partially limit the rate of VPg uridylylation at
concentrations of VPg well above its K0.5 value. We propose
that the increased affinity of 3BC(D) for the uridylylation com-
plex when serving as the VPg donor would cause 3BC(D)
release to limit the rate of VPg uridylylation. Release of 3BCD
would be slower than 3BC for the reason provided above.
Slow turnover in the steady state that is driven by product
release is the paradigm for a processive, polymerase-catalyzed
reaction (32). Consistentwith product release limiting turnover
of 3BC is the finding that 3BC uridylylation was more proces-
sive than VPg uridylylation (Fig. 2C). The inability to chase
VPg-pU into VPg-pUpU mandates a processive reaction.
Release of 3BCD-pUpU would be slower than 3BC due to the
increased interaction of this protein with the uridylylation
complex as discussed above. It would bemost advantageous for
release of the uridylylated product to be coupled to transfer to
the 3 end of plus- or minus-strand RNA. We envisage two
possible mechanisms for this coupling. It is possible that bind-
ing of oriR in the 3 end of plus-strand RNA or the functional
equivalent in the 3 end of minus-strand RNA stimulates
release. Alternatively, it is possible that proteolysis of the uridy-
lylated 3BCD protein bound to the 3 end of plus- or minus-
strand RNA to remove 3D stimulates release.We conclude that
the lower-than-expected uridylylation efficiency observed in
vitromay be biologically relevant.
Our studies were consistent with the existence of two inde-
pendent pathways for P3 polyprotein processing (Fig. 7, B and
D). The major pathway produced 3AB and 3CD. Impaired
cleavage between 3B and 3C activated cleavage between 3C and
3D, yielding 3ABC and 3D (Fig. 7, B and C). 3CD is highly
resistant to cleavage when present in its normal location, the
cytoplasm and nucleoplasm (1). 3AB is targeted to membranes
(1). If P3 is cleaved into 3AB and 3CD in the cytoplasm, fol-
lowed by movement of 3AB to membranes, then inhibition of
3B-3C cleavage would take the intact precursor to membranes.
Perhaps in this environment, the conformation of 3CD is
altered in a manner that leads to 3C-3D cleavage. The minor
pathway produced 3A and 3BCD; this pathway was not per-
turbed (Fig. 7, B and C). Under normal conditions, processed
3D is difficult to detect (Fig. 7, B and C), suggesting that pro-
cessed 3D originates from the minor pathway. Only processed
3Dwould exhibit polymerase activity (39, 42).We propose that
the minor pathway is involved in producing all of the proteins
that participate directly in genome replication, including the
VPg donor employed for uridylylation and RNA synthesis.
The major pathway would then be involved in the virus-host
functions of 3AB and 3CD (43–45). It is not clear what deter-
mines whether a P3 precursor is processed by the major or
minor pathway. The major pathway could represent a
default pathway that is bypassed by interaction of the P3
Picornavirus VPg Uridylylation Mechanism
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precursor with viral RNA. Additional studies will be
required to address this question.
Semler and co-workers (46) have also suggested two inde-
pendent processing pathways for the P3 precursor based on
pulse-chase experiments. Their model is consistent with ours
in that processed 3C and 3D do not originate from 3CD.
A recent study by Wimmer and co-workers (26) has shown
that a P3 precursor encoding the uridylylation inactivating Y3F
mutation in 3B (3AB*CD, where the asterisk denotes the
mutant 3B) cannot be rescued by creating a 3BAB*CD precur-
sor but can be rescued by creating a 3ABAB*CDprecursor. This
study revealed a function for Tyr-3 in the context of 3AB for
formation of a complex with 3CD or 3Dpol that is required for
some unknown aspect of genome replication. Given the require-
ment for two distinct functions for Tyr-3 in genome replication,
this mutant allele could not be used to prove the VPg donor
employed in vivo. However, cleavage between the amino-termi-
nal 3ABof 3ABAB*CDwas absolutely essential for genome rep-
lication, consistent with our hypothesis that a 3BCD precursor
is employed in vivo. In the case of the Wimmer mutant, this
precursor would be 3BAB*CD. A prediction of this hypothesis
is that 3ABAB*CD incapable of releasing the amino-terminal
3AB should be complemented in trans by 3BAB*CD.
The ability to produce any RNA in the absence of 3CD is
surprising. 3CD is thought to be required for most (if not all)
polyprotein-processing events (1). However, P2 and P3 proc-
essing was as robust as wild type (Fig. 7). Perhaps precursors
larger than 3CD function in vivo. This possibility would provide
an alternative explanation for the very low cleavage efficiency of
both 3C and 3CD in vitro (47). 3CD is more robust at P1 (cap-
sid) precursor processing. Therefore, the inability to recover
virus from mutated genomic RNA (data not shown) could be
attributed to the absence of 3CD. 3CD is also implicated in the
switch from translation to replication (48–50). The Gly-Gly
mutant may be “switch-defective.” There was an incongruence
between the kinetics of luciferase production (Fig. 6B) and the
kinetics of RNA synthesis (Fig. 8) assessed byNorthern analysis
that was consistent with enhanced translation of the mutant
replicon.
In conclusion, this study provides very compelling evidence
for use of a 3B(VPg)-containing precursor instead of 3AB for
uridylylation and RNA synthesis in vivo. A unique pathway
appears to exist for processing of the P3 to produce 3B-contain-
ing precursors functioning in genome replication. Use of this
3B-containing precursor will ensure processive uridylylation,
as well as permit regulated, coupled transfer of the uridylylated
product to the 3 end of either plus- orminus-strand RNA. This
model represents a paradigm shift relative to existingmodels of
picornavirus genome replication. Therefore, future studies
must scrutinize thismodel and determine the extent towhich it
applies to picornaviruses other than poliovirus.
Acknowledgments—We thank Saikat Kumar B. Ghosh for purifying
the 3AB protein, Zachary J. Reitman for purifying active PV 3C
protease, and Mehul Suthar for construction of the pET26Ub-N-
His plasmid.
REFERENCES
1. Semler, B. L., and Wimmer, E. (eds) (2002)Molecular Biology of Picorna-
viruses, American Society for Microbiology, Washington, DC
2. Pathak, H. B., Ghosh, S. K., Roberts, A. W., Sharma, S. D., Yoder, J. D.,
Arnold, J. J., Gohara, D. W., Barton, D. J., Paul, A. V., and Cameron, C. E.
(2002) J. Biol. Chem. 277, 31551–31562
3. Pathak, H. B., Arnold, J. J., Wiegand, P. N., Hargittai, M. R., and Cameron,
C. E. (2007) J. Biol. Chem. 282, 16202–16213
4. Shen, M., Wang, Q., Yang, Y., Pathak, H. B., Arnold, J. J., Castro, C.,
Lemon, S. M., and Cameron, C. E. (2007) J. Virol. 81, 12485–12495
5. Shen, M., Reitman, Z. J., Zhao, Y., Moustafa, I., Wang, Q., Arnold, J. J.,
Pathak, H. B., and Cameron, C. E. (2008) J. Biol. Chem. 283, 875–888
6. Paul, A. V., van Boom, J. H., Filippov, D., and Wimmer, E. (1998) Nature
393, 280–284
7. Paul, A. V., Rieder, E., Kim, D.W., van Boom, J. H., andWimmer, E. (2000)
J. Virol. 74, 10359–10370
8. Gerber, K., Wimmer, E., and Paul, A. V. (2001) J. Virol. 75, 10979–10990
9. Yang, Y., Rijnbrand, R., McKnight, K. L.,Wimmer, E., Paul, A., Martin, A.,
and Lemon, S. M. (2002) J. Virol. 76, 7485–7494
10. Mason, P. W., Bezborodova, S. V., and Henry, T. M. (2002) J. Virol. 76,
9686–9694
11. vanOoij,M. J., Vogt, D. A., Paul, A., Castro, C., Kuijpers, J., vanKuppeveld,
F. J., Cameron, C. E., Wimmer, E., Andino, R., and Melchers, W. J. (2006)
J. Gen. Virol. 87, 103–113
12. Rieder, E., Paul, A. V., Kim, D.W., van Boom, J. H., andWimmer, E. (2000)
J. Virol. 74, 10371–10380
13. Paul, A. V., Yin, J., Mugavero, J., Rieder, E., Liu, Y., andWimmer, E. (2003)
J. Biol. Chem. 278, 43951–43960
14. Yin, J., Paul, A. V., Wimmer, E., and Rieder, E. (2003) J. Virol. 77,
5152–5166
15. Murray, K. E., and Barton, D. J. (2003) J. Virol. 77, 4739–4750
16. Morasco, B. J., Sharma, N., Parilla, J., and Flanegan, J. B. (2003) J. Virol. 77,
5136–5144
17. Thiviyanathan, V., Yang, Y., Kaluarachchi, K., Rijnbrand, R., Gorenstein,
D. G., and Lemon, S. M. (2004) Proc. Natl. Acad. Sci. U. S. A. 101,
12688–12693
18. Yang, Y., Rijnbrand, R., Watowich, S., and Lemon, S. M. (2004) J. Biol.
Chem. 279, 12659–12667
19. Amero, C. D., Arnold, J. J., Moustafa, I. M., Cameron, C. E., and Foster,
M. P. (2008) J. Virol. 82, 4363–4370
20. Korneeva, V. S., and Cameron, C. E. (2007) J. Biol. Chem. 282,
16135–16145
21. Arnold, J. J., and Cameron, C. E. (2000) J. Biol. Chem. 275, 5329–5336
22. Barton, D. J., Black, E. P., and Flanegan, J. B. (1995) J. Virol. 69,
5516–5527
23. Racaniello, V. R. (2007) in Fields Virology (Knipe, D. M., Howley, P. M.,
Griffin, D. E., Lamb, R. A., Martin, M. A., Roizman, B., and Straus, S. E.,
eds) 4th Ed., pp. 795–838, Lippincott-Raven Publishers, Philadelphia
24. Koch, F., and Koch, G. (1985) The Molecular Biology of Poliovirus, pp.
311–371, Springer-Verlag, Inc., New York
25. Wong, I., and Lohman, T. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,
5428–5432
26. Liu, Y., Franco, D., Paul, A. V., and Wimmer, E. (2007) J. Virol. 81,
5669–5684
27. Cao, X., and Wimmer, E. (1996) EMBO J. 15, 23–33
28. Baltimore, D., Girard, M., and Darnell, J. E. (1966) Virology 29, 179–189
29. van Ooij, M. J., Polacek, C., Glaudemans, D. H., Kuijpers, J., van Kuppe-
veld, F. J., Andino, R., Agol, V. I., andMelchers, W. J. (2006)Nucleic Acids
Res. 34, 2953–2965
30. Richards, O. C., Spagnolo, J. F., Lyle, J. M., Vleck, S. E., Kuchta, R. D., and
Kirkegaard, K. (2006) J. Virol. 80, 7405–7415
31. Arnold, J. J., Ghosh, S. K., and Cameron, C. E. (1999) J. Biol. Chem. 274,
37060–37069
32. Arnold, J. J., Gohara, D. W., and Cameron, C. E. (2004) Biochemistry 43,
5138–5148
33. Ferrer-Orta, C., Arias, A., Agudo, R., Perez-Luque, R., Escarmis, C., Do-
mingo, E., and Verdaguer, N. (2006) EMBO J. 25, 880–888
Picornavirus VPg Uridylylation Mechanism
NOVEMBER 7, 2008 • VOLUME 283 • NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 30687
34. Nayak, A., Goodfellow, I. G., Woolaway, K. E., Birtley, J., Curry, S., and
Belsham, G. J. (2006) J. Virol. 80, 9865–9875
35. Hall, D. J., and Palmenberg, A. C. (1996) J. Virol. 70, 5954–5961
36. Lama, J., Sanz, M. A., and Rodriguez, P. L. (1995) J. Biol. Chem. 270,
14430–14438
37. Kusov, Y. Y., Morace, G., Probst, C., and Gauss-Muller, V. (1997) Virus
Res. 51, 151–157
38. Paul, A. V., Peters, J., Mugavero, J., Yin, J., van Boom, J. H., and Wimmer,
E. (2003) J. Virol. 77, 891–904
39. Marcotte, L. L., Wass, A. B., Gohara, D. W., Pathak, H. B., Arnold, J. J.,
Filman, D. J., Cameron, C. E., and Hogle, J. M. (2007) J. Virol. 81,
3583–3596
40. Nayak, A., Goodfellow, I. G., and Belsham, G. J. (2005) J. Virol. 79,
7698–7706
41. Boerner, J. E., Lyle, J. M., Daijogo, S., Semler, B. L., Schultz, S. C., Kirkeg-
aard, K., and Richards, O. C. (2005) J. Virol. 79, 7803–7811
42. Thompson, A. A., and Peersen, O. B. (2004) EMBO J. 23, 3462–3471
43. Doedens, J. R., and Kirkegaard, K. (1995) EMBO J. 14, 894–907
44. Wessels, E., Duijsings, D., Niu, T. K., Neumann, S., Oorschot, V. M., de
Lange, F., Lanke, K. H., Klumperman, J., Henke, A., Jackson, C. L.,
Melchers, W. J., and van Kuppeveld, F. J. (2006) Dev. Cell 11, 191–201
45. Belov, G. A., and Ehrenfeld, E. (2007) Cell Cycle 6, 36–38
46. Lawson, M. A., and Semler, B. L. (1992) Virology 191, 309–320
47. Parsley, T. B., Cornell, C. T., and Semler, B. L. (1999) J. Biol. Chem. 274,
12867–12876
48. Gamarnik, A. V., and Andino, R. (1998) Genes Dev. 12, 2293–2304
49. Verlinden, Y., Cuconati, A., Wimmer, E., and Rombau, B. (2002) Arch.
Virol. 147, 731–744
50. Perera, R., Daijogo, S.,Walter, B. L., Nguyen, J. H., and Semler, B. L. (2007)
J. Virol. 81, 8919–8932
Picornavirus VPg Uridylylation Mechanism
30688 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283 • NUMBER 45 • NOVEMBER 7, 2008
Cameron
Harsh B. Pathak, Hyung Suk Oh, Ian G. Goodfellow, Jamie J. Arnold and Craig E.
RATE-LIMITING STEPS IN oriI-DEPENDENT VPg URIDYLYLATION
Picornavirus Genome Replication: ROLES OF PRECURSOR PROTEINS AND
doi: 10.1074/jbc.M806101200 originally published online September 8, 2008
2008, 283:30677-30688.J. Biol. Chem. 
 10.1074/jbc.M806101200Access the most updated version of this article at doi: 
 Alerts: 
When a correction for this article is posted•
When this article is cited•




This article cites 47 references, 33 of which can be accessed free at
SUPPLEMENTAL DATA 
Picornavirus genome replication: Roles of precursor proteins and rate-limiting steps 
in oriI-dependent VPg uridylylation* 
Harsh B. Pathak1, Hyung Suk Oh, Ian G. Goodfellow†, Jamie J. Arnold,  
and Craig E. Cameron 
Department of Biochemistry and Molecular Biology, Pennsylvania State University, 
University Park, Pennsylvania 16802; †Department of Virology, Faculty of Medicine, 
Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK 
Running Title: Picornavirus VPg uridylylation mechanism 
Address correspondence to: Craig E. Cameron, Department of Biochemistry and 
Molecular Biology, Pennsylvania State University, 201 Althouse Laboratory, University 
Park, PA 16802, Tel.: 814-863-8705; Fax: 814-865-7927; E-mail: cec9@psu.edu
2 
EXPERIMENTAL PROCEDURES 
Construction of expression plasmids for 3BC, 
3BCD, 3AB, and 3CProtease − To make the 
expression plasmid for 3BC, oligos 1 – 4 (Table 
S1 lists all oligonucleotides used in this study; 
oligonucleotides were from Invitrogen life 
technologies and Integrated DNA Technologies, 
Inc.) were used to perform overlap-extension PCR 
using the viral cDNA (pMoRA, also known as 
pXpA-rib+polyAlong (1)) as template.  The 3BC 
region was cloned into the pET26Ub-C-His 
plasmid (2) using SacII and BamHI sites to give 
the pET26Ub-3BC-C147G-Chis plasmid.  In order 
to change the tyrosine at the third amino acid 
position in 3BC to phenylalanine, oligos 2 and 5 
were used to amplify the 3BC region from the 
pET26Ub-3BC-C147G-Chis plasmid.  This 
fragment was cloned into the pET26Ub-Chis 
plasmid using SacII and BamHI sites to obtain the 
pET26Ub-3BC-Y3F-C147G-Chis.  To make the 
3BCD expression plasmid, oligos 1, 17, 3, and 4, 
were used to perform overlap-extension PCR 
using the viral cDNA (pMoRA) as template.  The 
PCR product was disgested and cloned into the 
pET26Ub-3CD-C147G-Chis plasmid (Arnold and 
Cameron, unpublished results) using the SacII and 
AflII sites to give the pET26Ub-3BCD-C147G-
Chis plasmid.  In order to clone 3AB, oligos 10 
and 11 were used for PCR to amplify the 3AB 
region with pMoRA as template.  The PCR 
product was cloned into pET26Ub using SacII and 
EcoRI sites to obtain pET26Ub-3AB.  
In order to generate an active 3C protease 
clone, oligos 8 and 9 were used to amplify the 3C 
region using pMoRA as template.  The PCR 
product was cloned into the pET26Ub-N-His 
plasmid using the BamHI and EcoRI sites.  The 
pET26Ub-N-His plasmid is designed such that an 
N-terminal 6-histidine tag is produced when
cloned into the BamHI site.  The resulting plasmid
was labeled pET26Ub-3CProtease-Nhis.  DNA
sequencing at the Penn State Nucleic Acid Facility
was used to verify the integrity of the above
clones.
Expression and purification of 3BC, 3BC-Y3F, 
3BCD, 3CPro, 3AB, 3Dpol and, 3C − 3Dpol and 
3C were purified as described previously (2). 
Wild-type 3BC and the 3BC Y3F mutant were 
expressed using the ubiquitin fusion system 
described previously (3).  BL21(DE3)pCG1 cells 
containing either the pET26Ub-3BC-C147G-Chis 
or the pET26Ub-3BC-Y3F-C147G-Chis plasmid 
were grown overnight at 30 ºC in 100 mL of 
NZCYM  supplemented with kanamycin at 25 
µg/mL (K25), chloramphenicol at 20 µg/mL 
(C20), and dextrose at 0.1%.  The overnight 
cultures were used to seed 2 L of NZCYM 
K25/C20-supplemented media to an OD600 of 0.05.  
Cells were grown at 37 ºC until an OD600 of 1 was 
reached.  Cells were chilled to 25 ºC and induced 
by addition of isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final 
concentration of 500 μM.  Cells were grown for 4 
h at 25 ºC and harvested.  Cell pellets were 
weighed and stored at –80 ºC.  Frozen cell pellets 
were thawed on ice and suspended in lysis buffer 1 
(100 mM potassium phosphate, pH 8.0, 20% 
glycerol, 10 mM 2-mercaptoethanol (β-ME), 5.6 
µg/mL pepstatin A, 4 μg/mL leupeptin, 0.5 mM 
EDTA, and 60 μM ZnCl2) at a concentration 4 mL 
of buffer per g of cell pellet.  Cells were 
homogenized using a Dounce homogenizer; cells 
were lysed by passing through a French pressure 
cell at a pressure per square inch of 20,000. 
Phenylmethyl-sulfonyl fluoride (PMSF) and 
nonidet P-40 (NP-40) were added after lysis to 
final concentrations of 2 mM and 0.1% v/v, 
respectively.  Polyethylenimine (PEI) was slowly 
added to a final concentration of 0.25% v/v to the 
lysate in order to precipitate nucleic acid.  The 
lysate was stirred slowly at 4 °C for 30 min and 
then centrifuged in a Beckman JA-30.50 Ti rotor 
for 30 min at 24,000 rpm at 4 °C.  The PEI 
supernatant was diluted 5-fold, conductivity 
adjusted to 50 mM NaCl, and loaded at 1 mL/min 
onto a phosphocellulose (Whatman, P-11) column 
that was equilibrated with buffer A (50 mM 
HEPES, pH 7.5, 20% glycerol, 10 mM β-ME, and 
0.1% NP-40) containing 50 mM NaCl. 
Approximately 1 mL of resin bed volume was 
used per 20 mg of total protein.  Protein 
concentration was measured by using the BioRad 
protein assay.  The column was washed to baseline 
with buffer A containing 50 mM NaCl and protein 
3 
was eluted by using a six-column-volume, linear 
gradient from 50 to 2 M NaCl in buffer A. 
Fractions (1/10th the bed volume of the column) 
were collected, assayed for purity by SDS-PAGE, 
and pooled.  The protein concentration of the pool 
was adjusted to 1 mg/mL; the pool was loaded 
onto a Ni-NTA Agarose (Qiagen) column 
equilibrated with buffer A containing 1 M NaCl 
and 20 mM imidazole.  Approximately 0.5 mL 
resin bed volume was used per 50 mg total protein.  
The column was washed with 20 column volumes 
of buffer A containing 1 M NaCl and 20 mM 
imidazole.  Protein was eluted from the Ni-NTA 
column using buffer A containing 1 M NaCl and 
500 mM imidazole.  Fractions (0.5 mL) were 
collected until the concentration of the eluted 
protein fell below the desired value.  The high 
NaCl and imidazole concentrations were reduced 
from the fractions by dialysis against buffer A 
containing 200 mM NaCl using Spectra/Por 
dialysis tubing with a MWCO of 6000 − 8000 Da. 
SDS-PAGE was used to assess the purity of the 
eluted fractions.  Protein concentration was 
determined by using the following extinction 
coefficients: 0.008960 μM-1·cm-1 (3BC-C147G) 
and 0.007680 μM-1·cm-1 (3BC-Y3F-C147G). 
These values were determined by using the protein 
parameters tool on the ExPASy site 
http://us.expasy.org/tools/protparam.html).  The 
absorbance values were measured at 280 nm in 6 
M guanidine-HCl, pH 6.5.  Conductivities of the 
fractions were measured; fractions were then 
aliquoted, and stored at – 80 °C. 
3BCD was expressed as described above 
for 3BC.  Frozen cells pellets were and lysed in 
lysis buffer 1 containing 500mM NaCl.  PMSF 
and NP-40 were added after lysis to final 
concentrations of 2 mM and 0.1% v/v, 
respectively.  PEI was as added as described above 
for the 3BC purification.  After centrifugation, the 
PEI supernatant was saved and ammonium sulfate 
was added to 40% saturation and centrifuged again 
for 30 min at 24,000 rpm at 4 °C.  The ammonium 
sulfate pellet was resuspended in 40 mL 
ammonium sulfate resuspension buffer (50 mM 
HEPES pH 7.5, 20% glycerol, and 500 mM NaCl).  
Protein concentration was determined by using the 
BioRad protein assay and the concentration was 
adjusted to 1mg/mL prior to loading onto a 1 mL 
Ni-NTA agarose column pre-equilibrated with 10 
column volumes of Ni equilibration buffer (same 
as ammonium sulfate resuspension buffer).  Bound 
protein was eluted with Ni elution buffer (50 mM 
HEPES pH7.5, 20% glycerol, 500 mM NaCl, and 
500 mM imidazole).  SDS-PAGE was used to 
assess the purity of the eluted fractions.  The 
protein concentration of fractions was determined 
by measuring the absorbance values at 280 nm in 
6 M guanidine-HCl, pH 6.5 using an extinction 
coefficient of 0.008469 μM-1·cm-1.  Conductivities 
of the fractions were measured; fractions were 
then aliquoted, and stored at – 80 °C. 
The 3CPro was expressed as described 
above for 3BC, however, only a 100 mL culture 
was used.  Cell pellets were thawed and lysed as 
described above using lysis buffer 1 lacking 
EDTA and ZnCl2.  PMSF and NP-40 were added 
after lysis to final concentrations of 2 mM and 
0.1% v/v, respectively.  The lysates were clarified 
by centrifugation in a Beckman JA-30.50 Ti rotor 
for 30 min at 24,000 rpm at 4 °C.  The lysate 
supernatants were passed over Ni-NTA Spin 
columns (Qiagen).  The columns were equilibrated 
prior to loading and washed after loading with 
buffer A containing 500 mM NaCl according to 
the manufacture’s protocol.  Protein was eluted in 
two 100-µL fractions using buffer A containing 
500 mM NaCl and 500 mM imidazole.  Protein 
concentrations were determined by measuring the 
absorbance at a wavelength of 280 nm using the 
same extinction coefficients as used for the wild-
type proteins.  Conductivities of the fractions were 
measured and the fractions were then aliquoted 
and stored at – 80 °C. 
3AB was also expressed using the 
ubiquitin fusion system.  BL21(DE3)pCG1 cells 
containing the pET26Ub-3AB plasmid were 
grown overnight at 30 ºC in 100 mL of NZCYM 
supplemented with K25, C20, and 0.1% dextrose. 
The overnight cultures were used to seed 1 L of 
NZCYM K25/C20/0.1% dextrose-supplemented 
media to an OD600 of 0.05.  Cells were grown at 37 
ºC until an OD600 of 1.5 was reached.  Cells were 
chilled to 25 ºC and induced by addition of IPTG 
to a final concentration of 500 μM.  Cells were 
grown for 4 h at 25 ºC and harvested.  Cell pellets 
were weighed and stored at – 80 ºC.  3AB 
purification was performed using a modified 
version of a protocol described previously (4). 
Frozen cell pellets were thawed and lysed as 
described above using lysis buffer 2 (50 mM Tris-
4 
HCl, pH 7.6, 20% glycerol, 1 mM DTT, 1 μg/mL 
pepstatin A, 1 μg/mL leupeptin, 0.5 mM EDTA, 
and 100 mM NaCl).  PMSF was added after lysis 
to a final concentration of 1 mM.  The lysate was 
centrifuged in a Beckman Ti-60 rotor for 30 min at 
30,000 rpm at 4 °C.  The pellet was suspended in 
10 mL of solubilization buffer (50 mM Tris-HCl, 
pH 8.5, 20% glycerol, 1 mM DTT, 1 mM EDTA, 
50 mM NaCl, 0.5% NP-40) and centrifuged in a 
Beckman Ti-60 rotor for 30 min at 30,000 rpm at 
4 °C.  The supernatant was saved and this 
extraction procedure was repeated two more times. 
The second and third supernatants containing 3AB 
were combined and the conductivity and protein 
concentration was adjusted to 25 mM and 1 
mg/mL, respectively, using dilution buffer (Tris-
HCl, pH 8.5, 20% glycerol, 1 mM DTT, and 0.1% 
NP-40).  This diluted pool was then passed 
through a 10 mL DEAE-cellulose (Whatman, 
DE52) column connected in tandem to a 5 mL S-
sepharose (GE Healthcare) column.  DEAE was 
cycled following the manufacture’s protocol prior 
to use.  Both columns were equilibrated with the 
dilution buffer containing 25 mM NaCl.  1 mL of 
DEAE resin was used for every 10 mg of total 
protein and 1 mL of S-sepharose was used for 
every 20 mg of total protein in the initial pool. 
The S column was then washed using buffer S (25 
mM MOPS, pH 7.2, 20% glycerol, 1 mM β-ME, 
0.1% NP-40) containing 50 mM NaCl.  Fractions 
were eluted using buffer S containing 200 mM 
NaCl.  Protein concentrations were determined as 
described above using an extinction coefficient of 
0.012090 μM-1·cm-1.  Conductivities of the 
fractions were measured; fractions were then 
aliquoted, and stored at – 80 °C.      
Transcription and purification of 61nt oriI − OriI 
for the VPg uridylylation reaction was transcribed 
from pUC18-61nt-oriI plasmid (2) linearized using 
the BstZ17 I site.  A 4-ml transcription reaction 
(40 mM HEPES, pH 7.5, 32 mM magnesium 
acetate, 40 mM DTT, 2 mM Spermidine, 28 mM 
NTPs, 25 µg/mL linearized template, and 25 
µg/mL T7 RNA polymerase) at 37 ºC for 2 h was 
followed by removal of magnesium pyrophosphate 
by centrifugation for 2 minutes.  The supernatant 
was treated with RQ1DNase (1 U/µg of template; 
Promega) for 30 min to remove the template; two 
phenol/chloroform extractions followed by a 
chloroform extraction were performed to 
deproteinate the RNA.  Next, the RNA was 
precipitated with ammonium acetate, washed with 
70% ethanol, and the pellet was suspended in 50% 
formamide.  This provided the starting material for 
gel purification.  The entire volume was loaded 
onto a 10% acrylamide, 50% formamide gel (18 
cm × 24 cm × 2 mm).  The gel was run at 25 mA 
for approximately 4 h (the band corresponding to 
the full length oriI had migrated to the middle of 
the gel by this time, as determined by the 
migration of bromophenol blue and xylene cyanol 
indicator dyes).  The oriI band was excised from 
the gel by using UV-shadowing using a TLC plate 
with a fluorescent indicator (PEI Cellulose F, EM 
Science).  The gel piece was cut into tiny squares 
and placed in an Elutrap electrophoresis chamber 
(Schleicher & Schuell).  The eluted RNA was 
precipitated with ammonium acetate, washed with 
70% ethanol, and suspended in Tris-EDTA.  This 
was then passed over two Sephadex G-25 (Sigma) 
spin columns.  RNA concentration was calculated 
by measuring absorbance at 260 nm.  The 
extinction coefficient was calculated for the 61-nt 
oriI plus three guanosine residues that are 
transcribed at the 5’ end of oriI (0.749400 µM-
1·cm-1) (5). 
OriI for the RNA-filter binding assay was 
transcribed as above, however, only a 40 µL 
reaction was performed and [α-32P]UTP (0.33 µM 
final concentration) was included in the reaction. 
Following DNase treatment, the RNA was spun 
through a Micropure-EZ centrifugal filter (Amicon 
Bioseparations, Millipore) to remove any protein 
from the RNA according to the manufacturer’s 
instructions.  The RNA was precipitated with 
ammonium acetate; the pellet was suspended in 
Tris-EDTA and then passed through two G25 
Sephadex spin columns to remove free 
nucleotides.  To confirm RNA quality and 
sufficient removal of nucleotides, analysis by 
PAGE and a Typhoon 8600 scanner (Molecular 
Dynamics) in the storage phosphor mode was 
performed. 
Construction of mutated replicons clones − 
Mutation of the Gln-Gly cleavage site between 3B 
and 3C to Gly-Gly in the poliovirus replicon, 
pRLucRA (1,6), required overlap-extension PCR 
amplification using oligos 6, 7, 12, and 13 and the 
pRLucRA plasmid as template.  The amplified 
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fragment was cloned into the pRLucRA plasmid 
using the SpeI and BglII sites.  Screening for the 
introduction of a new NheI site identified correct 
clones.  The clone was labeled pRLucRA-3B-3C-
Gly-Gly.  The NheI site was introduced via a silent 
mutation in the forward oligo (oligo 12).  In order 
to verify that this silent mutation did not produce 
any adverse effects, oligos 12 and 13 were used to 
amplify this region from the pRLucRA plasmid. 
The amplified fragment was cloned into the 
pRLucRA plasmid and screened for the new NheI 
site.  This new replicon, referred to as pRLucRA-
3B-3C-WT, was used as the wild-type replicon for 
all of the replicon studies comparing the Wildtype 
and the Gly-Gly mutant.  The tyrosine at the third 
position of 3B was changed to phenylalanine by 
using overlap-extension PCR amplification with 
oligos 12 – 15 and pRLucRA-3B-3C-Gly-Gly as 
template.  Correct clones were identified as before. 
The resulting clone was labeled pRLucRA-3B-3C-
Y3F-Gly-Gly.  DNA sequencing at the Penn State 
Nucleic Acid Facility using pRLuc-BglII-r oligo 
(oligo 13) as primer, was used to verify the 
presence of the 3B-3C processing site mutation 
and the Y3F mutation. 
Transcription of subgenomic replicons and 
luciferase assays − RNA transcripts were 
generated from the pRLucRA plasmids after 
linearization with ApaI.  Transcription reactions, 
typically 20 µL, consisted of 350 mM HEPES, pH 
7.5, 32 mM magnesium acetate, 40 mM DTT, 2 
mM Spermidine, 28 mM NTPs, 0.5 µg template, 
and 0.5 µg T7 RNA polymerase.  Reactions were 
incubated at 37 ºC for 3 h followed by removal of 
magnesium pyrophosphate.  DNase treatment with 
RQ1DNase (Promega) was used to remove the 
template; lithium chloride precipitation of the 
RNA was used to remove unincorporated 
nucleotides.  RNA concentration was calculated 
by measuring absorbance at 260 nm, assuming an 
A260 of 1 was equivalent to 40 µg/mL. 
Luciferase assays were performed as 
described previously (2) with slight modifications 
as described here.  Only 5 µg of replicon RNA 
were used to electroporate 1.2 × 106 cells.  Cells 
were suspended in normal growth media 
(DMEM/F12 supplemented with 10% fetal bovine 
serum, 1% penicillin/streptomycin, 5 mL/1 × 106 
cells) following electroporation.  Light production 
was quantified for 10 seconds by using a Junior 
LB 9509 luminometer (Berthold Technologies). 
Protein concentration of the lysate supernatant was 
determined by using the BioRad Protein Assay 
reagent following the manufacture’s instructions. 
Relative light units (RLU) per µg of protein is 
reported. 
Western-blot analysis of replicon proteins − Cells 
were transfected with replicon RNA as described 
above.  Following 20 h of incubation at 34 °C, 
cells (1 × 106) were pelleted by centrifugation at 
14,000 × g for 2 min and lysed in 1× cell culture 
lysis reagent (CCLR, Promega, 50 µL). 
Luciferase activity and protein concentration were 
measured for the samples as described above.  For 
Western blot analysis, an equal volume of 2× 
SDS-PAGE dye (225 mM Tris, pH 6.8, 5% SDS, 
50% glycerol, 5% β-ME and 0.05% bromphenol 
blue) was added to the lysed cells.  An equal 
amount of RLU/µg of protein was used for 
Western blot analysis.  Proteins were separated by 
using 8% and 15% SDS-PAGE as indicated in the 
figure legend; transfer to nitrocellulose membrane 
(Osmonics, Inc. and/or GE Healthcare) was 
performed using the Genie transfer unit from Idea 
Scientific Company (Minneapolis, MN) for 50 
min at 24 V in transfer buffer (25 mM Tris-
Glycine/3 mM SDS/20% (v/v) methanol (pH 
8.3)); dry milk (5% (w/v)) in TBS-T (20 mM Tris, 
pH 7.6, 137 mM NaCl, 0.1% Tween 20) was used 
to block the membrane (the blocking and probing 
steps were performed at room temperature for 1 
h). Polyclonal anti-sera used to probe for viral 
proteins were produced in rabbit against purified 
recombinant poliovirus proteins 3D, 3C-His, and 
3AB-His by Covance Research Products, Inc. 
(Denver, PA).  Anti-sera were capable of detecting 
at least 100 pg of purified protein at 1:1,000 
dilutions in TBS-T (1:1000 for the anti-rabbit HRP 
secondary).  3D (PA 473) anti-serum was used at a 
1:10,000 dilution in TBS-T; 3C (PA 474) and and 
3AB (PA 485) anti-sera were used at 1:5,000 
dilutions in TBS-T.  Immunocomplexes were 
detected by using a horseradish peroxidase 
conjugated goat anti-rabbit secondary antibody 
(Santa Cruz Biotechnology) at a 1:10,000 dilution 
in TBS-T and the ECL system (GE Healthcare). 
Kodak Biomax MR film was used to visualize the 
chemiluminescence. 
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Generation and purification of polyclonal PV 
VPg, PV 3C and HCV NS5A antisera − N-
terminally and C-terminally KLH-conjugated 
VPgs were used to raise polyclonal antisera in 
rabbits.  The following VPg segment was used as 
antigen: TGLPNKKPNVPTIRTAKVQ.  The two 
antisera (PA 797 and PA 796, respectively) were 
combined and purified as described below. 
Purified PV 3C-His, PV 3D and HCV NS5A-His 
were used to raise polyclonal antisera in rabbit 
(PA 474, PA 473, and PA 413, respectively). 
Antisera were precleared by centrifugation at 
16000 × g at 4 °C for 15 min.  Ammonium sulfate 
was then added to 33% saturation over a 30 min 
period while the antisera were stirred in the cold 
room.  After addition of all of the ammonium 
sulfate, the mixture was stirred an additional 30 
min.  The precipitated material was pelleted by 
centrifugation at 50000×g at 4 °C for 30 min.  The 
pellet was suspended in load buffer (20 mM Tris, 
pH 8.0, 50 mM NaCl) to approximately the same 
volume as the starting antisera volume and 
dialyzed overnight at 4 °C against the load buffer. 
Conductivity of the dialyzed sample was adjusted 
to 50 mM by dilution using the load buffer 
containing no NaCl.  This sample was then passed 
through a column packed using DEAE Affi-gel 
Blue gel (BioRad).  A bed volume of 1-mL resin 
per 5 mg of total protein was used.  The column 
was prepared by washing with 5 column volumes 
of pre-wash buffer (100 mM acetic acid, 1.4 M 
NaCl, and 40% isoprpanol) and then 10 column 
volumes of the load buffer.  Fractions (one-third 
the column volume) were collected.  Fractions 
were analyzed by SDS-PAGE and protein 
concentration measured using the BioRad assay. 
Fractions containing IgGs were pooled and 
concentrated approximately 40-fold using a YM10 
Amicon Centriprep centrifugal concentrator 
(Millipore).  Protein concentration was measured 
using the BioRad assay; sodium azide was added 
to a final concentration of 0.1%, and the samples 
were aliquoted and placed at – 80 °C.  The 
purified antisera were capable of detecting 100 pg 
of purified protein at a 1:1,000 dilution in TBS-T 
(1:1,000 for the anti-rabbit HRP secondary).
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Table S1.  Oligonucleotides used in this study 
Restriction sites are shown in bold; codons containing nucleotide changes are italicized.  
No. Name Sequence
1 3B-SacII-f 5’-GCG GAA TTC CCG CGG TGG AGG AGC ATA CAC TGG TTT-3’ 
2 3C-Chis-BamHI-r 5’-GCG GGT ACC GGA TCC TTG ACT CTG AGT GAA GTA-3’ 
3 3C-C147G-f 5’-CCA ACC AGA GCA GGA CAG GGT GGT GGA GTC ATC ACA-3’ 
4 3C-C147G-r 5’-TGT GAT GAC TCC ACC ACC CTG TCC TGC TCT GGT TGG-3’ 
5 3B-Y3F-SacII-f 5’-GGC TCC GCG GTG GAG GAG CAT TCA CTG GTT TAC CAA AC-3’ 
6 3B-3C-QGtoGG-f 5’-CGG ACA GCA AAG GTA GGA GGA CCA GGG TTC GAT TAC-3’ 
7 3B-3C-QGtoGG-r 5’-GTA ATC GAA CCC TGG TCC TCC TAC CTT TGC TGT CCG-3’ 
8 3C-N-His-BamHI-f 5’-GCG GGA TCC TCC GGA GGA CCA GGG TTC GAT TAC GC-3’ 
9 3C-PmeI-EcoRI-r 5’-GCG GAA TTC GTT TAA ACT TAC TAT TGA CTC TGA GTG AAG TA-3’ 
10 3A-SacII-f 5’-GCG GAA TTC CCG CGG TGG AGG ACC ACT CCA GTA T-3’ 
11 3B-EcoRI-r 5’-GCG GAA TTC GGA TCC TTA CTA TTG TAC CTT TGC TGT CCG-3’ 
12a pRLuC-SpeI-f 5’-GCG ACT AGT TAT TAT AAC TAG GAA CTA TGA AGA CAC CAC AAC AGT GCT 
AGC TAC CCT GGC CCT TC-3’ 
13 pRLuc-BglII-r 5’-CGC AGA TCT CCA CTT CTT TGC CA-3’ 
14 pRLucRA-3B-Y3F-f 5’-GGA CAC CAG GGA GCA TTC ACT GGT TTA CC-3’ 
15 pRLucRA-3B-Y3F-r 5’-GGT AAA CCA GTG AAT GCT CCC TGG TGT CC-3’ 
16 3D-AflII-f 5’-AAC GAT CCC AGG CTT AAG ACA GAC TTT GAG-3’ 
17 3D-AflII-r 5’-AAA GTC TGT CTT AAG CCT GGG ATC G-3’ 
18 3D-KpnI-r 5’-TTG AGT TAA AAA TTG AGG TAC CTG AGC AGC CAG AT-3’ 
a An NheI site was introduced via a silent mutation 
